246 related articles for article (PubMed ID: 30185813)
1. JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity.
Liu Y; Long YH; Wang SQ; Zhang YY; Li YF; Mi JS; Yu CH; Li DY; Zhang JH; Zhang XJ
Oncogene; 2019 Feb; 38(7):980-997. PubMed ID: 30185813
[TBL] [Abstract][Full Text] [Related]
2. Livin promotes colon cancer progression by regulation of H2A.X
Ge Y; Liu BL; Cui JP; Li SQ
Life Sci; 2019 Oct; 234():116788. PubMed ID: 31445935
[TBL] [Abstract][Full Text] [Related]
3. KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39.
Li Y; Yu P; Zou Y; Cai W; Sun W; Han N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4257-4265. PubMed ID: 31736361
[TBL] [Abstract][Full Text] [Related]
4. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
[TBL] [Abstract][Full Text] [Related]
5. Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6).
Unoki M; Masuda A; Dohmae N; Arita K; Yoshimatsu M; Iwai Y; Fukui Y; Ueda K; Hamamoto R; Shirakawa M; Sasaki H; Nakamura Y
J Biol Chem; 2013 Mar; 288(9):6053-62. PubMed ID: 23303181
[TBL] [Abstract][Full Text] [Related]
6. JMJD6-STAT3
Wang K; Du B; Xu B; Lv X
Biofactors; 2020 Sep; 46(5):839-848. PubMed ID: 31958364
[TBL] [Abstract][Full Text] [Related]
7. Both EZH2 and JMJD6 regulate cell cycle genes in breast cancer.
Biswas A; Mukherjee G; Kondaiah P; Desai KV
BMC Cancer; 2020 Nov; 20(1):1159. PubMed ID: 33246425
[TBL] [Abstract][Full Text] [Related]
8. JMJD6 induces HOTAIR, an oncogenic lincRNA, by physically interacting with its proximal promoter.
Biswas A; Shettar A; Mukherjee G; Kondaiah P; Desai KV
Biochem J; 2018 Jan; 475(1):355-371. PubMed ID: 29229759
[TBL] [Abstract][Full Text] [Related]
9. The hydroxylation activity of Jmjd6 is required for its homo-oligomerization.
Han G; Li J; Wang Y; Li X; Mao H; Liu Y; Chen CD
J Cell Biochem; 2012 May; 113(5):1663-70. PubMed ID: 22189873
[TBL] [Abstract][Full Text] [Related]
10. Jumonji domain-containing protein 6 protein and its role in cancer.
Yang J; Chen S; Yang Y; Ma X; Shao B; Yang S; Wei Y; Wei X
Cell Prolif; 2020 Feb; 53(2):e12747. PubMed ID: 31961032
[TBL] [Abstract][Full Text] [Related]
11. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of N-(1-(6-(substituted phenyl)-pyridazin-3-yl)-piperidine-3-yl)-amine derivatives as JMJD6 inhibitors.
Qian Y; Ao M; Li B; Kuang Z; Wang X; Cao Y; Li J; Qiu Y; Guo K; Fang M; Wu Z
Bioorg Chem; 2022 Dec; 129():106119. PubMed ID: 36116323
[TBL] [Abstract][Full Text] [Related]
13. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV
Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Jmjd6 cellular localization and testing for its involvement in histone demethylation.
Hahn P; Wegener I; Burrells A; Böse J; Wolf A; Erck C; Butler D; Schofield CJ; Böttger A; Lengeling A
PLoS One; 2010 Oct; 5(10):e13769. PubMed ID: 21060799
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
16. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
17. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4.
Wan J; Liu H; Yang L; Ma L; Liu J; Ming L
Int J Cancer; 2019 May; 144(10):2489-2500. PubMed ID: 30125344
[TBL] [Abstract][Full Text] [Related]
18. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.
Wang F; He L; Huangyang P; Liang J; Si W; Yan R; Han X; Liu S; Gui B; Li W; Miao D; Jing C; Liu Z; Pei F; Sun L; Shang Y
PLoS Biol; 2014 Mar; 12(3):e1001819. PubMed ID: 24667498
[TBL] [Abstract][Full Text] [Related]
19. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
[TBL] [Abstract][Full Text] [Related]
20. Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.
Palmer KR; Tong S; Tuohey L; Cannon P; Ye L; Hannan NJ; Brownfoot FC; Illanes SE; Kaitu'u-Lino TJ
Biol Reprod; 2016 Mar; 94(3):59. PubMed ID: 26819475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
